Skip to main content

New Products: Feb 4, 2011


Origene Technologies this week released a full-length human MTOR protein, a protein kinase involved in regulation of cell growth, proliferation, motility, and survival, as well as protein synthesis and transcription.

Produced in mammalian cells, the protein is intended for use in high-throughput functional screening assays and drug target discovery and is the first commercially available full-length human MTOR protein, the company said.

Shimadzu and Perfinity Biosciences this week announced that they will be launching the Perfinity Workstation at Pittcon 2011.

The Workstation is a multi-column sample prep device that automates protein separation and mass-spec sample preparation, integrating affinity selection, buffer exchange, proteolysis, and desalting steps. It will allow researchers to start with serum and in ten minutes have peptides ready for LC/MS analysis, the companies said. Shimadzu will be previewing the platform via video next week at its booth at the Mass Spectrometry: Applications to the Clinical Lab conference in San Diego.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.